Literature DB >> 10737975

Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene.

E Mornet1.   

Abstract

Hypophosphatasia is an inborn error of metabolism caused by a deficiency of liver-, bone- or kidney-type alkaline phosphatase due to mutations in the tissue-nonspecific alkaline phosphatase (ALPL) gene. Most of the 65 distinct mutations described to date are missense mutations, a result which must be correlated with the great variability of clinical expression ranging from stillbirth without mineralized bone to pathologic fractures developing only late in adulthood. Correlations of genotype and phenotype have been established on the basis of clinical data exhibited by the patients, transfection studies, computer-assisted modeling, and examination of biochemical properties of ALP in cultured fibroblasts of patients. Screening for mutations in the TNSALP gene allows genetic counseling and prenatal diagnosis of the disease in families with severe forms of hypophosphatasia, and screening may also be helpful in confirming diagnosis of hypophosphatasia when biochemical and clinical data are not clear. Screening is also the necessary first step in further studies to elucidate dominant transmission of the disease and of liver-, bone- and kidney-type alkaline phosphatase activity mechanism. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737975     DOI: 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

1.  Cloning and expression pattern of alkaline phosphatase during the development of Paralichthys olivaceus.

Authors:  Z Y Shi; X W Chen; Y F Gu
Journal:  Fish Physiol Biochem       Date:  2010-10-05       Impact factor: 2.794

2.  Adult hypophosphatasia with painful periarticular calcification treated with surgical resection.

Authors:  Kei-Ichiro Iida; Jun-Ichi Fukushi; Toshifumi Fujiwara; Yoshinao Oda; Yukihide Iwamoto
Journal:  J Bone Miner Metab       Date:  2011-12-15       Impact factor: 2.626

3.  Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153-->Asp substitution, a cause of perinatal hypophosphatasia.

Authors:  Masahiro Ito; Norio Amizuka; Hidehiro Ozawa; Kimimitsu Oda
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Structural studies of human alkaline phosphatase in complex with strontium: implication for its secondary effect in bones.

Authors:  Paola Llinas; Michel Masella; Torgny Stigbrand; André Ménez; Enrico A Stura; Marie Hélène Le Du
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

5.  Molecular evolution of the tissue-nonspecific alkaline phosphatase allows prediction and validation of missense mutations responsible for hypophosphatasia.

Authors:  Jérémie Silvent; Barbara Gasse; Etienne Mornet; Jean-Yves Sire
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

Review 6.  PXE, a Mysterious Inborn Error Clarified.

Authors:  Piet Borst; András Váradi; Koen van de Wetering
Journal:  Trends Biochem Sci       Date:  2018-11-13       Impact factor: 13.807

Review 7.  Direct and Functional Biomarkers of Vitamin B6 Status.

Authors:  Per Magne Ueland; Arve Ulvik; Luisa Rios-Avila; Øivind Midttun; Jesse F Gregory
Journal:  Annu Rev Nutr       Date:  2015-05-13       Impact factor: 11.848

8.  Hypophosphatasia may lead to bone fragility: don't miss it.

Authors:  Pierre Moulin; Frédéric Vaysse; Eric Bieth; Etienne Mornet; Isabelle Gennero; Sara Dalicieux-Laurencin; Christiane Baunin; Marie Thérèse Tauber; Jérôme Sales De Gauzy; Jean Pierre Salles
Journal:  Eur J Pediatr       Date:  2008-09-26       Impact factor: 3.183

9.  Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers.

Authors:  Satoshi Sobue; Keith Tan; Linda Shaw; Gary Layton; Rita Hust
Journal:  Eur J Clin Pharmacol       Date:  2004-04-22       Impact factor: 2.953

10.  Neurosurgical aspects of childhood hypophosphatasia.

Authors:  H Collmann; E Mornet; S Gattenlöhner; C Beck; H Girschick
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.